Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Yunfu Deng"'
Autor:
Wenjie Chen, Wen Li, Zhenkun Liu, Guangzhi Ma, Yunfu Deng, Xiaogang Li, Zhu Wang, Qinghua zhou
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract To identify the prognostic biomarker of the competitive endogenous RNA (ceRNA) and explore the tumor infiltrating immune cells (TIICs) which might be the potential prognostic factors in lung adenocarcinoma. In addition, we also try to explai
Externí odkaz:
https://doaj.org/article/3d9ebf6a06744f4e9027ffbdbbcdf30a
Autor:
Cheng Ai, Guangzhi Ma, Yunfu Deng, Qiangqiang Zheng, Yingcai Gen, Wen Li, Yang Li, Lingling Zu, Qinghua Zhou
Publikováno v:
Thoracic Cancer, Vol 11, Iss 3, Pp 640-650 (2020)
Abstract Background Nm23‐H1 gene has been found to be an inhibitor of tumor metastasis in lung cancer. MicroRNAs (miRNAs) play key roles in tumor metastasis through multiple signaling pathways. This study explored whether the nm23‐H1 gene could i
Externí odkaz:
https://doaj.org/article/35def3297d2d4113a78d2bc8ac1985bd
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundThe preoperative systemic immune-inflammation index (SII) is correlated with prognosis in several malignancies. The aim of this study was to investigate the prognosis value of SII in patients with resected breast cancer.Materials and Method
Externí odkaz:
https://doaj.org/article/f9c4d63d933c42b3a0d028f3c6ae5f48
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Objectives: MET protein expression has been reported to be in relevance with the survival of NSCLC patients in various studies, yet the results were inconsistent. The purpose of our study set out to determine the prognostic role of both c-MET and p-M
Externí odkaz:
https://doaj.org/article/23ab005d2ec64e929e3d51bf3cb00271
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Background: Ki-67 is a widely used marker of tumor proliferation, but the prognostic value of ki-67 in triple-negative breast cancer (TNBC) has not been comprehensively reviewed. This meta-analysis was conducted to evaluate the association between ki
Externí odkaz:
https://doaj.org/article/14de6e4a554a45d6b63e18d989c412db
Autor:
Shi-Yong Sun, Wenyi Wei, Taofeek K. Owonikoko, Suresh S. Ramalingam, Songqing Fan, Qiming Wang, Yunfu Deng, Zhen Chen, Changjiang Hu, Karin A. Vallega, Jianping Guo, Guoqing Qian
Osimertinib decreases PD-L1 mRNA levels (A-C) and exerts differential effects on reducing PD-L1 induced by EGF and INFg (D and E), which might increase PD-L1 via different mechanisms (F), in EGFRm NSCLC cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34a0b3d45d18d8305a3dc6c1c27b2b08
https://doi.org/10.1158/1541-7786.22525832.v1
https://doi.org/10.1158/1541-7786.22525832.v1
Autor:
Shi-Yong Sun, Wenyi Wei, Taofeek K. Owonikoko, Suresh S. Ramalingam, Songqing Fan, Qiming Wang, Yunfu Deng, Zhen Chen, Changjiang Hu, Karin A. Vallega, Jianping Guo, Guoqing Qian
Expression of programmed death-ligand 1 (PD-L1) on cancer cells is a critical mechanism contributing to immunosuppression and immune escape. PD-L1 expression may also affect therapeutic outcomes of epidermal growth factor receptor (EGFR)-targeted the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e1e9ae1ba9f6598f30ecc27221f2c22
https://doi.org/10.1158/1541-7786.c.6544928
https://doi.org/10.1158/1541-7786.c.6544928
Autor:
Yunfu Deng, Guangzhi Ma, Karin A. Vallega, Dongsheng Wang, Mingliang Wang, Changwei Wang, Shaomeng Wang, Suresh S. Ramalingam, Shi-Yong Sun
Publikováno v:
Cancer Gene Therapy. 29:1558-1569
SHP2, a protein tyrosine phosphatase, plays a critical role in fully activating oncogenic signaling pathways such as Ras/MAPK downstream of cell surface tyrosine receptors (e.g., EGFR), which are often activated in human cancers, and thus has emerged
Publikováno v:
2022 IEEE 25th International Conference on Intelligent Transportation Systems (ITSC).
Autor:
Wenyi Wei, Songqing Fan, Guoqing Qian, Karin A. Vallega, Qiming Wang, Yunfu Deng, Zhen Chen, Suresh S. Ramalingam, Jianping Guo, Taofeek K. Owonikoko, Changjiang Hu, Shi-Yong Sun
Publikováno v:
Mol Cancer Res
Expression of programmed death-ligand 1 (PD-L1) on cancer cells is a critical mechanism contributing to immunosuppression and immune escape. PD-L1 expression may also affect therapeutic outcomes of epidermal growth factor receptor (EGFR)-targeted the